Cytokine release syndrome complicated with severe rashes induced by nivolumab plus ipilimumab therapy in a patient with non‐small cell lung cancer: A case report

Cytokine release syndrome complicated with severe rashes induced by nivolumab plus ipilimumab therapy in a patient with non‐small cell lung cancer: A case report

Abstract Cytokine release syndrome (CRS) is a severe and life‐threatening toxicity typically reported in chimeric antigen receptor T cell therapy and is rarely reported in immune checkpoint inhibitor (ICI) therapy. This study reports the case of a 75‐year‐old Japanese woman who received nivolumab pl...

Full description

Bibliographic Details
Main Authors: Toshiharu Tsutsui, Koki Hata, Makoto Kawaguchi, Hiroaki Kobayashi, Yumiko Kakizaki, Yoshihiro Miyashita
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:Thoracic Cancer
Subjects:
cytokine release syndrome
immune checkpoint inhibitors
immune‐related adverse events
Online Access:https://doi.org/10.1111/1759-7714.15015

Similar Items

Similar Items